top of page

Investment Sees Immediate Progress

Organisation News

13 Dec 2022

Gemina's recent investment into RAPIvD sees immediate progress

Gemina Labs is a biosensor and diagnostic company with a transformative, patented, proprietary chemistry technology platform that powers next generation testing platforms for a wide range of pathogens that affect human health and wellness. Our technologies drive testing platforms that are fast, affordable and accurate, and easily self-administered. Our own product pipeline

bottom of page